In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...

Genome-wide association studies (GWASs) have linked genetic variants to neuropsychiatric disorders, but their regulatory roles in non-coding regions remain largely unclear. Using the LUHMES neuronal ...

A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells.

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

The state's life sciences industry, which generated $3.3 billion in economic activity in 2023, could be severely impacted by ...

Accumulation of fat molecules is detrimental to the cell. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have made a breakthrough in ...

The UMass Chan Medical School in Worcester announced Thursday it received a $35 million gift that aims to advance research to ...

In a new study published in Science, a Belgian research team explores how genetic switches controlling gene activity define ...

D-Wave Quantum Inc. (NYSE: QBTS) and the Jülich Supercomputing Centre (JSC) at Forschungszentrum Jülich (FZJ) announced today ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

Researchers at University of Galway have created the world's largest collection of digital microbes—nearly a quarter million ...